![Uttam Yashwant Patil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uttam Yashwant Patil
Directeur Général chez
ABVC BIOPHARMA, INC.
Fortune : 102 123 $ au 31/05/2026
Profil
Uttam Yashwant Patil currently works at AiBtl BioPharma, Inc., as Co-Chief Executive Officer from 2025, ABVC BioPharma, Inc., as Chief Executive & Financial Officer from 2023, Biokey, Inc., as Chief Operating & Scientific Officer from 2023, and Rgene Corp., as Manager-Research & Development from 2023.
Dr. Patil received his doctorate degree from National Tsing-Hua University and undergraduate degree and graduate degree from the University of Pune.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABVC BIOPHARMA, INC. 0,28% | 27/02/2026 | 72 428 ( 0,28% ) | 102 123 $ | 31/05/2026 |
Postes actifs de Uttam Yashwant Patil
| Sociétés | Poste | Début |
|---|---|---|
| ABVC BIOPHARMA, INC. | Directeur Général | 23/06/2023 |
Biokey, Inc.
 Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Directeur des opérations | 01/05/2023 |
Rgene Corp.
 Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Directeur Technique/Scientifique/R&D | 01/05/2023 |
Formation de Uttam Yashwant Patil
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
National Tsing-Hua University
 National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pune
 University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABVC BioPharma, Inc.
 ABVC BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops drugs and medical devices in the fields of oncology, ophthalmology and central nervous system | Health Technology |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
